Download Whitepaper
Anticipating Scale
Infrastructure, Strategy, and the future of ATMPs in Europe
This whitepaper explores the current landscape and future of advanced therapy medicinal products (ATMPs) in Europe, focusing on the infrastructure and strategic considerations required to support the anticipated scale of cell and gene therapies. Explore some the opportunities and challenges facing ATMPs, including:
- Regulatory and Market Access Challenges
- Operational Complexities Straining the Supply Chain
- Building Resilient and Scalable Supply Chains
- Outsourcing to Minimize Capital Expenditure
- Adapting to Geopolitical and Market Dynamics
- Designing the Future of ATMP Delivery